Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Event, Trade Show

Click Therapeutics to Participate in the BTIG Digital Health Forum


Click Therapeutics, Inc. ("Click"), a leader in Digital Therapeuticstm as prescription medical treatments, today announced that David Benshoof Klein, Co-Founder and CEO, and Randall Stanicky, Chief Financial Officer, will take part in the virtual BTIG Digital Health Forum on Monday, November 15, 2021. As part of the event, Mr. Klein will participate in a digital therapeutics panel discussion: "Setting the Pace: Commercializing Prescription Digital Therapeutics (PDTs) and Expanding the Pipeline" at 2 p.m. ET.

About Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click's Digital Therapeuticstm enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click's industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click's lead prescription program has recently entered a pivotal, fully remote, randomized, controlled trial on the Verily platform for the treatment of Major Depressive Disorder in up to 540 adults. For more information on Click, visit ClickTherapeutics.com.


These press releases may also interest you

at 01:15
Technavio categorizes the global vascular endothelial growth factor (VEGF) inhibitors market as a part of the pharmaceutical market within the overall healthcare industry. The vascular endothelial growth factor (VEGF) inhibitors market research...

at 01:05
BeiGene, Ltd. , a global biotechnology company focused on developing and commercializing innovative medicines worldwide, yesterday announced the opening of a new regional office in Basel, Switzerland. BeiGene has built a European organization,...

at 01:00
BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI-enabled drug...

at 00:00
Clinical trial professionals need to harness the power within their clinical trial data. This free webinar will show them how to take control. There's no doubt the volume, variety and velocity of data has never been greater, with the number of unique...

at 00:00
Drug and device manufactures need to understand their company's culture of quality and how it might be improved. Have their efforts made to date fallen on deaf ears? Is there a way to measure what's working, and more importantly what's not, so...

16 mai 2022
In 2007, after many years in the recruiting industry and entrepreneurship in his DNA, TurningPoint's CEO & Founder, Ken Schmitt, decided it was time to change the standard for recruiting. He envisioned a high-touch, personalized approach to...



News published on 10 november 2021 at 07:10 and distributed by: